| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +5.7K | 100% | $1.75 | +$9.98K |
| Sells | 0 | ||||
| Net | +1 | +5.7K | 100% | +$9.98K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Aaron G.L. Fletcher | Director, 10%+ Owner | $11.7M | Jun 7, 2024 | ||
| Leslie W. Kreis | Director, 10%+ Owner | $11.7M | Jun 7, 2024 | ||
| Ogden CAP Associates, LLC | 10%+ Owner | $2.32M | Oct 13, 2021 | ||
| BIOS Memory SPV I, LP | 10%+ Owner | $1.5M | Oct 13, 2021 | ||
| Bios Clinical Opportunity Fund, LP | Director, 10%+ Owner | $525K | Nov 8, 2023 | ||
| Lisa Ricciardi | CEO & President, Director | $510K | +$9.98K | +2% | Mar 14, 2024 |
| Mark H. Breedlove | Director | $433K | Oct 13, 2021 | ||
| Anthony Caggiano | Chief Medical Officer | $324K | Feb 15, 2024 | ||
| John Brendan Doyle | Chief Financial Officer | $236K | May 1, 2024 | ||
| Peggy Wallace | Director | $102K | Jun 7, 2024 | ||
| Ellen B. Richstone | Director | $47.8K | Jun 7, 2024 | ||
| Jack A. Khattar | Director | $28.3K | Jun 7, 2024 | ||
| Brett P. Monia | Director | $28.3K | Jun 7, 2024 | ||
| Golden Seeds Cognition Therapeutics LLC | 10%+ Owner | Sep 27, 2022 | |||
| James O'Brien | Chief Financial Officer | Mar 23, 2022 | |||
| Andrew J. Einhorn | Interim CFO | Aug 12, 2022 | |||
| BP Directors, LP | Affiliate of director | Jan 31, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|